Zurueck zur Suche

Reporte zur Charge UJ933AC

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

29Reporte angezeigt
0Todesfaelle
3Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 5 CT 3 AZ 3 IN 2 PA 1 MA 1 NM 1 MI 1 MN 1 FL 1 WI 1 VA 1

VAERS 2527819

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933ac

kritisch
Staat
IN
Alter
84,0
Geschlecht
M
Eingang
09.12.2022
Impfdatum
10.11.2022
Beginn
06.12.2022
Tage bis Beginn
26,0
Dosis
UNK
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Alanine aminotransferase increased Anaemia Anion gap Aspartate aminotransferase increased Asthenia Bacterial test negative Base excess Basophil count decreased Basophil percentage decreased Bladder scan Blood albumin decreased Blood alkaline phosphatase normal Blood bicarbonate normal Blood bilirubin increased Blood bilirubin normal Blood calcium decreased Blood chloride normal

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: DO on December 06, 2022 07:39 EST Verified By: DO on December 06, 2022 07:39 EST Encounter Info: Inpatient, 12/06/22 - * Final Report * Chief Complaint shortness of breath History of Present Illness/Subjective Patient is an elderly male with history of COPD who presented to ED w/ cough and generalized weakness. Does have shortness of breath but reports no significant deviation from baseline. Symptoms started about 1 week ago and have progressively worsened since that time. Reports his wife had flulike symptoms about 2 days prior to his onset of symptoms. He has had significantly decreased oral intake. He has been so weak that he fell a couple days ago. However, denies head trauma or injuries. He is remained afebrile. He is unable to get up independently due to the severity of his weakness. In the ED he was discovered to have influenza A, elevated trop, aki, elevated bnp, and is requiring 4L O2 via oxymask. He denies chest pain, productive cough, admits to some wheezing. Patient states he is thirsty. Review of Systems A complete, 13-system review was performed and was negative except for as noted in the HPI. Physical Exam/Objective Vital Signs (most recent and range for last 24 hours) Temp (CEL) 37 (37-37) Temp (FAHR) 98.6 (98.6-98.6), BP 112/86 (112-112)/(86-86), HR 100 (100-107), RR 20 (18-20), O2Sat 92 (92-92) Neurologic (most recent and range for last 24 hours) GCS 15(15-15) Patient Weight Current Daily Weight: 68.7 kg 12/06/22 Previous Daily Weight: 68.7 kg 12/06/22 BMI: 24.1 12/06/22 Normal Weight (BMI 18.5-24.9) Patient Height Current Height: 169 cm 12/06/22 Constitutional: No acute distress, frail appearing, weak, appears dry Eyes: no scleral icterus, no conjunctival injection, dry mucuous membranes HENT: no edema, atraumatic Neck: normal ROM Cardiovascular: tachycardic, regular rhythm, No edema Pulmonary: no respiratory distress, rhonchi bilaterally, with mild wheeze Abdomen: nondistended, no tenderness, no rebound, noguarding MSK: atraumatic, no deformities, no cyanosis Neurologic: motor function grossly intact, sensation grossly intact Skin: dry, warm Psych: calm and cooperative Assessment/Plan admit to med/surg 1. Influenza A J10.1 2. CHF (congestive heart failure) I50.9 3. COPD exacerbation J44.1 supportive care and supplemental o2 not a candidate for tamiflu due to onset of symptoms being approx 7 days prior droplet isolation resp assessment doxycycline for possible atypical pneumonia duonebs likely not a chf exacerbation given patient is dry 4. Acute on chronic renal failure N17.9 renal function is improving with iv and supplemental o2 avoid nephrotoxic medications 5. Anemia D64.9 transfuse hg <7, drop in hg likely related to dilutional change, repeat hg in 4 hours 6. Thrombocytopenia D69.6 trend plt count, no dvt chemical ppx while platelets are <100K possibly due to influenza, cont to monitor 7. Elevated troponin R77.8 likely due to demand ischemia and initial hypoxia cont to trend trops until peaked, cardio eval prn if not improving no chest pain at present and ecg does not demonstrate evidence of ACS cont to monitor 8. Diabetes mellitus with hyperglycemia E11.65 accuchecks, iss, diabetic diet, hold home meds for now 9. Elevated bilirubin R17 resolved Orders: acetaminophen, 650 mg, Orally, Tablet, Q4H, PRN, Pain, Mild PO (1-3 out of 10)/Fever, 12/06/22 4:46:00 EST Dextrose 10% in Water 500 mL, Total Volume (mL) = 500, IV, 12/06/22 4:46:00 EST, PRN - See Comments doxycycline, 100 mg, IVPB, Injection, BID, 12/06/22 10:00:00 EST, 100 mL/hr, Infuse Over 1 Hours, Total Volume (mL) = 100 fluticasone-vilanterol, 1 Puff, Inhalation, Aerosol Powder, MDI/DPI Inhaler Treatment, Daily, 12/06/22 9:00:00 EST glucagon, 1 mg, IM, Injection, Unscheduled, PRN, Hypoglycemia, 12/06/22 4:46:00 EST glucose, Per Glucose Level, IV Push, Injection, Unscheduled, PRN, Low Blood Sugar, 12/06/22 4:46:00 EST insulin lispro, Sliding Scale, Subcutaneous, Injection, With Glucose Testing, PRN, Serum Glucose, 12/06/22 4:46:00 EST methylPREDNISolone, 40 mg, IV Push, Injection, Daily, 12/06/22 9:00:00 EST 180 gm Carb per day Diet Admit to Inpatient CAH Bladder Scan Call (Specify) Call Blood Glucose Call Diastolic Blood Pressure Call Heart Rate Call Mental Status Changes Call O2 Saturation Call Respiratory Distress Call Respiratory Rate Call Systolic Blood Pressure Call Temperature Call Urine Output CBC CBC w/Differential Comp Metabolic Panel Comp Metabolic Panel Electrocardiogram Fall Precautions Fluid Intake Requirement Gluc-Strip POC Hgb Hgb A1C HPLC Bld QN Initiate IV Care Protocols As Appropriate Initiate Mobility Protocol Initiate Oxygen Protocol Initiate Respiratory Protocol Initiate Skin and Wound Care Protocol Intake + Output Strict Level of Care Lipid Panel SerPl QN Magnesium SerPl QN Medical Service Medication Message to Nursing Message to Nursing Message to Nursing Nasal Cannula Notify Provider Notify Provider Notify Provider OT Evaluation and Treatment Patient Isolation Peripheral IV Insertion Phosphorus SerPl QN PT Evaluation and Treatment Reason for Not Ordering Long-acting Insulin Resp Evaluation or Assessment Resuscitation Status Sequential Compression Device Single Oxygen Saturation Telemetry Class III 24hr Recommendation Titrate FiO2 to Keep O2 Sat Troponin-I High Sensitivity TSH w FreeT4 reflex Turn Cough + Deep Breathe Vital Signs Weight Weight Code Status Resuscitation Status - Ordered -- 12/06/22 4:46:00 EST, Full Code Chronic Problem List Anemia CAD (coronary artery disease) Chronic cough Chronic HFrEF (heart failure with reduced ejection fraction) Chronic ITP (idiopathic thrombocytopenia) Colonic polyp COPD (chronic obstructive pulmonary disease) Dermatitis, atopic Diet-controlled diabetes mellitus Encounter for long-term current use of medication GERD (gastroesophageal reflux disease) Hematuria Hip pain History of hip replacement Hx of staphylococcal infection Hyperlipidemia Hypertension Intermittent claudication Macrocytosis Macrocytosis without anemia Mallet finger Nasal septal deviation Obstructive sleep apnea Psoriasis S/P implantation of automatic cardioverter/defibrillator (AICD) Skin lesion Snoring Stage 3 chronic kidney disease Tobacco use Vascular dementia Procedure/Surgical History ?Diabetic retinal eye exam (12/21/2021) ?Eye examination (12/20/2018) ?colonoscopy (08/01/2016) ?Hip replacement (07/01/2013) ?egd (05/09/2012) ?CABG - Coronary artery bypass graft (2002) ?Heart Sx 2004 ?Polypectomy ?Rt THR JWS 7/1/13 Surgical History Internal 08/01/2016 Colonscpy Diagnostic/Screen Medications Home Medications (17) Active acitretin 10 mg oral capsule 10 mg = 1 Capsule, Orally, Every Mon Wed Fri allopurinol 100 mg oral tablet 100 mg = 1 Tablet, Orally, BID amLODIPine 2.5 mg oral tablet , TAKE 1 TABLET BY MOUTH EVERY DAY apixaban 5 mg oral tablet 5 mg = 1 Tablet, Orally, BID aspirin 81 mg oral tablet 81 mg = 1 Tablet, Orally, Daily atorvastatin 20 mg oral tablet 20 mg = 1 Tablet, Orally, QHS Breo Ellipta 200 mCg-25 mCg inhalation powder 1 Puff, Inhalation, Daily Flomax 0.4 mg oral capsule 0.4 mg = 1 Capsule, Orally, Daily furosemide 40 mg oral tablet 40 mg = 1 Tablet, Orally, Daily Mapap Arthritis Pain 650 mg oral tablet, extended release 1,300 mg = 2 Tablet, Orally, Q8H memantine 5 mg oral tablet See Instructions, 1 Tablet Orally bid X 1 week then 2 in am 1 in pm x 1 week then 2 twice a day metoPROLOL tartrate 100 mg oral tablet 100 mg = 1 Tablet, Orally, BID multivitamin 1 Tablet, Orally, Daily Nitrostat 0.4 mg sublingual tablet 0.4 mg = 1 Tablet, PRN, Sublingually, Q5min omeprazole 20 mg oral delayed release capsule 20 mg = 1 Capsule, Orally, Daily valsartan 80 mg oral tablet 80 mg = 1 Tablet, Orally, Daily Vitamin C 500 mg oral tablet 500 mg = 1 Tablet, Orally, BID Active Scheduled Inpatient Medications doxycycline, Injection, 100 mg, IVPB, BID, Start: 12/06/22 10:00:00 fluticasone-vilanterol (Breo Ellipta 200 mCg-25 mCg inhalation powder), Aerosol Powder, 1 Puff, Inhalation, Daily, Start: 12/06/22 09:00:00 methylPREDNISolone (soluMEDROL), Injection, 40 mg, IV Push, Daily, Start: 12/06/22 09:00:00 Lactated Ringers 1,000 mL IV 150 mL/hr Dextrose 10% in Water 500 mL IV PRN - See Comments One-Time Medications Given 12/05/22 00:00:00 TO 12/06/22 07:39:23 None Reported PRN Medications (0600 - 0559) from 12/05 - 12/06 acetaminophen, 650 mg, Orally, Q4H, 0 Dose(s) glucagon, 1 mg, IM, Unscheduled, 0 Dose(s) glucose, Per Glucose Level , IV Push, Unscheduled, 0 Dose(s) insulin lispro, Sliding Scale , Subcutaneous, With Glucose Testing, 0 Dose(s) Allergies penicillins (Unknown) Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Home/Environment Lives with Spouse. Substance Abuse Denies Tobacco Tobacco Use: 10 or more cigarettes (1/2 pack or more)/day in last 30 days. Family History CAD - Coronary artery disease: Mother and Brother. DM (diabetes mellitus)...: Grandmother. Kidney disease: Brother and Brother.Negative: Mother and Father. Stroke: Mother. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 4.1 k/cumm (12/06/22 05:31:00) RBC: 2.55 million/cumm Low (12/06/22 05:31:00) Hgb: 9.7 GM/dL Low (12/06/22 05:31:00) Hct: 28.2 % Low (12/06/22 05:31:00) MCV: 111 fL High (12/06/22 05:31:00) MCH: 38 pg High (12/06/22 05:31:00) MCHC: 34.3 GM/dL (12/06/22 05:31:00) RDW: 13.3 % (12/06/22 05:31:00) Platelet: 62 k/cumm Low (12/06/22 05:31:00) MPV: 8.4 fL (12/06/22 05:31:00) Neutrophils %: 83 % (12/05/22 20:18:00) Lymphocytes %: 8 % (12/05/22 20:18:00) Monocytes %: 10 % (12/05/22 20:18:00) Eosinophils %: 0 % (12/05/22 20:18:00) Basophils %: 0 % (12/05/22 20:18:00) Absolute Neutrophil: 4.2 k/cumm (12/05/22 20:18:00) Absolute Lymphocyte: 0.4 k/cumm Low (12/05/22 20:18:00) Absolute Monocyte: 0.5 k/cumm (12/05/22 20:18:00) Absolute Eosinophil: 0 k/cumm (12/05/22 20:18:00) Absolute Basophil: 0 k/cumm (12/05/22 20:18:00) RBC Morphology: See description UC (12/05/22 20:18:00) Dacryocyte: Few (1+). (12/05/22 20:18:00) Macrocyte: Few (1+). (12/05/22 20:18:00) Microcyte: Few (1+). (12/05/22 20:18:00) Platelet Estimate: Decreased. (12/05/22 20:18:00) Chemistry: Sodium SerPl QN: 139 mmol/L (12/06/22 05:31:00) Potassium SerPl QN: 4.2 mmol/L (12/06/22 05:31:00) Chloride SerPl QN: 100 mmol/L (12/06/22 05:31:00) Carbon Dioxide SerPl QN: 24 mmol/L (12/06/22 05:31:00) Anion Gap: 15 mmol/L High (12/06/22 05:31:00) BUN SerPl QN: 50 mg/dL High (12/06/22 05:31:00) Creatinine SerPl QN: 2.12 mg/dL High (12/06/22 05:31:00) Estimated GFR (CKD-EPI, no race): 30 mL/min/1.73m2 Low (12/06/22 05:31:00) Estimated CRCL (CG): 24 mL/min Low (12/06/22 05:31:00) Glucose SerPl QN: 186 mg/dL High (12/06/22 05:31:00) Calcium Total SerPl QN: 8.4 mg/dL Low (12/06/22 05:31:00) Phosphorus SerPl QN: 3 mg/dL (12/06/22 05:31:00) Alkaline Phos SerPl QN: 60 Units/L (12/06/22 05:31:00) ALT SerPl QN: 41 Units/L (12/06/22 05:31:00) AST SerPl QN: 89 Units/L High (12/06/22 05:31:00) Bilirubin Total SerPl QN: 0.8 mg/dL (12/06/22 05:31:00) Total Protein SerPl QN: 5.6 GM/dL Low (12/06/22 05:31:00) Albumin SerPl QN: 3.1 GM/dL Low (12/06/22 05:31:00) Magnesium SerPl QN: 1.7 mg/dL (12/06/22 05:31:00) Troponin-I High Sensitivity: 78 ng/L High (12/06/22 05:31:00) BNP Pl QN: 636 pg/mL High (12/05/22 20:18:00) Lactate Venous Pl QN: 1.3 mmol/L (12/05/22 20:18:00) pH Bld Venous QN: 7.44 (12/05/22 20:18:00) PCO2 Bld Venous QN: 36 mmHg Low (12/05/22 20:18:00) PO2 Bld Venous QN: <35 Low (12/05/22 20:18:00) Base Excess Bld Venous: 1 mmol/L (12/05/22 20:18:00) Bicarb Bld Venous Calc: 24 mmol/L (12/05/22 20:18:00) O2 Sat Bld Venous Calc: 68 % (12/05/22 20:18:00) Patient Temperature: 37 DegC (12/05/22 20:18:00) TSH 3rd Gen SerPl QN: 0.75 mcU/mL (12/06/22 06:00:00) All Other Labs: COVID 19 Specimen Source: Nasopharyngeal (12/05/22 19:50:00) Coronavirus SARS-CoV2 Rapid: Not Detected (12/05/22 19:50:00) Micro - Last 7 days Rapid Influenza Method: PCR - Liat (12/05/22 19:50:00) Rapid Influenza A PCR: Detected Abnormal (12/05/22 19:50:00) Rapid Influenza B PCR: Not Detected (12/05/22 19:50:00) Diagnostics Radiology Results - Last 24 hours Across Visits 12/05/2022 20:20 - XR Chest PA or AP Portable IMPRESSION: Airspace opacities, left greater than right, which are new comparedto prior chest radiograph on 3/23/2022, however were present on theprior CT on 8/15/2022. Signature Line Electronically Signed on 12/06/22 07:39 EST ________________________________________________________ DO

Weitere VAERSDATA-Felder
Praegender Schweregrund
Coma scale
Hospital-Tage
-
Labordaten
Molecular Diagnostic Tests MRSA PCR * (c) See comment Modified Staph aureus PCR * (c) See comment Modified COVID 19 Specimen Source Nasopharyngeal Coronavirus SARS-CoV2 Rapid * Not Detected Microbiology Studies - Bacterial Blood CX NEG In Progress NEG In Progress Viral FS Rapid Influenza Method PCR - Liat Rapid Influenza A PCR * (A) Detected Rapid Influenza B PCR * Not Detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2650085

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

moderat
Staat
FL
Alter
79,0
Geschlecht
M
Eingang
27.06.2023
Impfdatum
17.10.2022
Beginn
01.06.2023
Tage bis Beginn
227,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exercise tolerance decreased Injection site pain Mobility decreased

Symptomtext

PATIENT BEGAN EXPERIENCING ARM PAIN RECENTLY (SPECIFIC TIME UNKNOWN) NEAR THE SITE OF MODERNA INJECTION RECEIVED 10/17/22. HIS PAIN FEELS DEEP IN THE ARM AND HAS PROGRESSIVELY GOTTEN WORSE, WITH SEVERE PAIN AT NIGHT. AT TIMES HE HAS TROUBLE LIFTING HIS ARM ABOVE HIS HEAD. HE DOES NOT RECALL ANY UNUSUAL/SEVERE PAIN SHORTLY AFTER THE INJECTION, AND ALSO RECEIVED FLUZONE HD IN THE OTHER ARM WITH NO ISSUES. THERE ISN'T AND WAS NEVER A BRUISE OR LUMP AT THE SITE. HE DOES LIFT ARM WEIGHTS ON A DAILY BASIS AND ONLY STOPPED FOR A COUPLE DAYS AFTER THE INJECTION.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
LEVOTHYROXINE, ROSUVASTATIN, LISINOPRIL, TAMSULOSIN
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2572274

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933ac

moderat
Staat
MI
Alter
73,0
Geschlecht
M
Eingang
31.01.2023
Impfdatum
26.01.2023
Beginn
27.01.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chest pain

Symptomtext

Chest pain day after vaccination...had to take nitroglycerin to relieve symptoms..no adverse effects according to patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
Has afib
Andere Medikamente
-
Allergien
none known
Vorherige Impfungen
Covid

VAERS 2539229

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge UJ933AC

moderat
Staat
PA
Alter
69,0
Geschlecht
M
Eingang
21.12.2022
Impfdatum
01.12.2022
Beginn
16.12.2022
Tage bis Beginn
15,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Albumin CSF decreased CSF glucose normal CSF immunoglobulin increased CSF lactate normal CSF lymphocyte count increased CSF monocyte count decreased CSF neutrophil count CSF protein normal Hypoaesthesia Lumbar puncture Muscular weakness Paraesthesia

Symptomtext

Bilateral weakness from knees down. Numbness and tingling progressed to hands. 12/16/22 presented to Hospital with symptoms. Reported having upper respiratory infection 1 week prior.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
7,0
Labordaten
12/19/22 Lumbar puncture-12/19/22 14:21 Glucose, CSF: 70 Protein, CSF: 26 IgG, CSF: 1.3 | 1.3 IgG Index, CSF: 0.4 Albumin, CSF: 16.2 | 16.2 Lactate CSF: 2.1 IgG Synthesis Rate, CSF: -3.9 CSF, Clot Formation: Negative CSF, Color (Uncentrifuged): Colorless CSF, Clarity: Clear CSF, Particulate Matter: Negative CSF, Tube Number: 4 Neutrophils, CSF: 3 CSF, Lymphocytes: 85 (H) CSF Monocytes/Macrophages: 12 (L) RBC, CSF: 0 CSF, Nucleated Cells: 3 Culture has no growth 2 days out. (H): Data is abnormally high (L): Data is abnormally low
Aktuelle Erkrankungen
-
Vorgeschichte
GERD, HTN, Kidney stone
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2521933

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933ac

moderat
Staat
IN
Alter
81,0
Geschlecht
F
Eingang
02.12.2022
Impfdatum
20.11.2022
Beginn
29.11.2022
Tage bis Beginn
9,0
Dosis
UNK
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute sinusitis Alanine aminotransferase normal Angiogram abnormal Angiogram pulmonary abnormal Anion gap Aortic aneurysm Aortic dilatation Arteriosclerosis Aspartate aminotransferase normal Asthenia Auscultation Back pain Bacterial test positive Base excess Basophil count decreased Basophil percentage decreased Bilirubin urine Blood albumin normal

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on November 29, 2022 17:01 Verified By: MD on November 29, 2022 17:57 Encounter Info: Inpatient, 11/29/22 - * Final Report * History of Present Illness/Subjective Chief Complaint: weakness HPI: Patient is an 80-year-old female presented to Emergency Department via EMS complaining of back pain that started 2 days ago additionally have been having some vomiting since yesterday oxygen saturation in 80s when EMS arrived at scene. Patient is now on 4 L oxygen and saturating in high 90s Patient's confused HPI is limited due to the altered mental state. Patient presented with a temperature of 101.5 heart rate monitor to respirations in high 20s to low 30s presenting blood pressure 219/88. Briefly she was given nicardipine in the emergency room and her blood pressure gradually improved temperature dropped to 99.7 and respirations continue to be high. Laboratory data was unremarkable except patient's troponin was 68 BNP 820 urinalysis showing moderate amount of hemoglobin rapid influenza positive: Negative. Review of Systems All 13 point review of systems were reviewed with the patient and are negative except as specified in the HPI Physical Exam/Objective Vital Signs (most recent and range for last 24 hours) None reported this timeframe Patient Weight Patient Height None Reported General: Alert and oriented, No Acute distress Eye: Pupils are equal, round and reactive to light HEENT: Normocephalic, atraumatic Neck: Supple, normal range of motion Oropharynx: No erythema or drainage. Respiratory: Lungs are clear to auscultation. basilar crackles Cardiovascular: Normal rate, Regular rhythm. s1 s2 positive Gastrointestinal: Soft, Non-tender. BS present all 4 quadrants Musculoskeletal: Normal range of motion, No focal tenderness Integumentary: Warm, Dry, No rash Neurologic: No focal weakness. Sensation intact. Normal mood and affect. cranial nerves grossly intact Assessment/Plan 1. Sepsis A41.9 Patient meets sepsis criteria secondary to high temperature tachycardia tachypnea and chest x-ray showing pneumonia. -Patient has been started on broad-spectrum antibiotics -We will gently hydrate the patient since patient's BNP is elevated to almost 1000. -Monitor for fluid overload. 2. Pneumonia J18.9 Follow-up on culture data, procalcitonin. -If procalcitonin level is less than 0.25 discontinue antibiotics she is likely having influenza pneumonia. 3. Altered mental state R41.82 See problem 1 and 2 4. Influenza J11.1 Patient will be given Tamiflu twice daily for 5 days. -Keep in droplet isolation. 5. Hypertensive urgency I16.0 Patient was briefly on nicardipine drip bp improved. will give metoprolol pushes if needed on the floor otherwise start home meds. 6. Elevated brain natriuretic peptide (BNP) level R79.89 Patient does not appear to be fluid overloaded but her BNP is sufficiently elevated. -Obtain 2D echocardiogram 7. Elevated troponin R77.8 Likely demand related. -Repeat troponin. 8. Lacunar infarction I63.81 This appears to be an old infarct but I am not certain since patient is having altered mental state I would like to get an MRI of her brain to rule out any acute problems. 9. Ascending aortic aneurysm I71.21 This is also quite large chest at the verge and patient might need repair. -We will refer this to primary care doctor for outpatient follow-up. 10. Hypokalemia E87.6 This will be monitored daily patient is mildly hypokalemic. -We will replace. 11. DM (diabetes mellitus), type 2 E11.9 Diabetes appears to be fairly well controlled. -No need for Lantus. -Continue with sliding scale insulin and low-carb diet. -Hypoglycemia protocol. 12. Hyperlipidemia E78.5 Resume statins 13. Morbid obesity E66.01 Counseling will be provided once patient is more alert and awake. Due to a high probability of clinically significant, life threatening deterioration, the patient required my highest level of preparedness to intervene emergently and I personally spent 52 minutes of critical care time directly and personally managing the patient. This critical care time included obtaining a history, examining the patient, pulse oximetry, ordering and reviewing the studies, arranging urgent treatment with development of a management plan, evaluation of the patient?s response to treatment, frequent reassessment, and discussions with other clinicians. The critical care time was performed to assess and manage the high probability of imminent, life-threatening deterioration that could result in multi-organ failure. It was exclusive of separately billable procedures and treating other patients and teaching time. Please see the MDM section and the rest of this note for further information on patient assessment and treatment. Code Status None Recorded Chronic Problem List Abnormal gait Arthralgia of multiple joints BMI 37.0-37.9, adult DM (diabetes mellitus), type 2 Heart murmur Hyperlipidemia Hypertension Left-sided chest wall pain Long term use of drug Morbid obesity Osteoarthritis Right knee DJD Procedure/Surgical History ?Colonoscopy (08/22/2007) ?Ankle fracture ?Eye surgery Medications Home Medications (11) Active amLODIPine 5 mg oral tablet 5 mg = 1 Tablet, Orally, Daily atorvastatin 20 mg oral tablet 20 mg = 1 Tablet, Orally, Daily Blood Glucose Meter Not Applicable, Other, Unscheduled Blood Glucose Test Strips Check daily, Other, Unscheduled, E11.65Z79.4 DME Walker (ONCE) Not Applicable, Other, Unscheduled, standard walker DME Wheelchair Not Applicable, Other, Unscheduled ibuprofen 200 mg oral capsule 200 mg = 1 Capsule, Orally, Q4H Lancet Device Not Applicable, Other, Unscheduled Lancets 1 Box, Other, Unscheduled, Use as needed to check blood sugars lisinopril-hydroCHLOROthiazide 20 mg-12.5 mg oral tablet 1 Tablet, Orally, Daily Misc Supplies See Instructions, Toilet seat riser with arms Active Scheduled Inpatient Medications niCARdipine PREMIX + Sodium Chloride 0.9% PREMIX IV Titrate - See Comments 5 mg/hr One-Time Medications Given 11/28/22 00:00:00 TO 11/29/22 17:01:20 None Reported PRN Medications (0600 - 0559) from 11/28 - 11/29 None Reported Allergies NKA No Known Medication Allergies Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Substance Abuse Denies Tobacco Tobacco Use: Former smoker, quit more than 30 days ago. Family History Diabetes mellitus type 2: Mother. Heart disease..: Mother. High blood pressure..: Mother. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 5.8 k/cumm (11/29/22 11:50:00) RBC: 4.14 million/cumm (11/29/22 11:50:00) Hgb: 11.8 GM/dL Low (11/29/22 11:50:00) Hct: 35.5 % (11/29/22 11:50:00) MCV: 86 fL (11/29/22 11:50:00) MCH: 28.5 pg (11/29/22 11:50:00) MCHC: 33.2 GM/dL (11/29/22 11:50:00) RDW: 14.3 % (11/29/22 11:50:00) Platelet: 302 k/cumm (11/29/22 11:50:00) MPV: 7.8 fL (11/29/22 11:50:00) Neutrophils %: 87 % (11/29/22 11:50:00) Lymphocytes %: 6 % (11/29/22 11:50:00) Monocytes %: 7 % (11/29/22 11:50:00) Eosinophils %: 0 % (11/29/22 11:50:00) Basophils %: 0 % (11/29/22 11:50:00) Absolute Neutrophil: 5 k/cumm (11/29/22 11:50:00) Absolute Lymphocyte: 0.3 k/cumm Low (11/29/22 11:50:00) Absolute Monocyte: 0.4 k/cumm (11/29/22 11:50:00) Absolute Eosinophil: 0 k/cumm (11/29/22 11:50:00) Absolute Basophil: 0 k/cumm (11/29/22 11:50:00) Chemistry: Sodium SerPl QN: 136 mmol/L (11/29/22 11:50:00) Potassium SerPl QN: 3.4 mmol/L Low (11/29/22 11:50:00) Chloride SerPl QN: 95 mmol/L Low (11/29/22 11:50:00) Carbon Dioxide SerPl QN: 31 mmol/L High (11/29/22 11:50:00) Anion Gap: 10 mmol/L (11/29/22 11:50:00) BUN SerPl QN: 15 mg/dL (11/29/22 11:50:00) Creatinine SerPl QN: 0.71 mg/dL (11/29/22 11:50:00) Estimated GFR (CKD-EPI, no race): 85 mL/min/1.73m2 (11/29/22 11:50:00) Estimated CRCL (CG): 70 mL/min (11/29/22 11:50:00) Glucose SerPl QN: 167 mg/dL High (11/29/22 11:50:00) Calcium Total SerPl QN: 9.9 mg/dL (11/29/22 11:50:00) Alkaline Phos SerPl QN: 77 Units/L (11/29/22 11:50:00) ALT SerPl QN: 11 Units/L (11/29/22 11:50:00) AST SerPl QN: 15 Units/L (11/29/22 11:50:00) Bilirubin Total SerPl QN: 0.6 mg/dL (11/29/22 11:50:00) Total Protein SerPl QN: 7.7 GM/dL (11/29/22 11:50:00) Albumin SerPl QN: 4.3 GM/dL (11/29/22 11:50:00) Troponin-I High Sensitivity: 68 ng/L High (11/29/22 11:50:00) BNP Pl QN: 820 pg/mL High (11/29/22 11:50:00) Lactate Venous Pl QN: 1.2 mmol/L (11/29/22 11:50:00) pH Bld Venous QN: 7.37 (11/29/22 11:50:00) PCO2 Bld Venous QN: 56 mmHg (11/29/22 11:50:00) PO2 Bld Venous QN: 40 mmHg (11/29/22 11:50:00) Base Excess Bld Venous: 6 mmol/L High (11/29/22 11:50:00) Bicarb Bld Venous Calc: 32 mmol/L High (11/29/22 11:50:00) O2 Sat Bld Venous Calc: 73 % (11/29/22 11:50:00) Patient Temperature: 37 DegC (11/29/22 11:50:00) Urine Studies: Color: Yellow (11/29/22 14:01:00) Clarity: Clear (11/29/22 14:01:00) Specific Gravity: 1.020 (11/29/22 14:01:00) pH: 6.0 (11/29/22 14:01:00) Protein: 100 Abnormal (11/29/22 14:01:00) Glucose: NEGATIVE (11/29/22 14:01:00) Ketones: NEGATIVE (11/29/22 14:01:00) Bilirubin: NEGATIVE (11/29/22 14:01:00) Hgb Ur: MODERATE. Abnormal (11/29/22 14:01:00) Nitrite: NEGATIVE (11/29/22 14:01:00) Urobilinogen: 1.0. (11/29/22 14:01:00) Leukocyte Esterase Ur: NEGATIVE (11/29/22 14:01:00) WBC: 0-5 (11/29/22 14:01:00) RBC: 3-5 Abnormal (11/29/22 14:01:00) Bacteria: Few Abnormal (11/29/22 14:01:00) Squamous Epithelial: Few (11/29/22 14:01:00) All Other Labs: COVID 19 Specimen Source: Nasal (11/29/22 11:34:00) Coronavirus SARS-CoV2 Rapid: Not Detected (11/29/22 11:34:00) Micro - Last 7 days Rapid Influenza Method: PCR - Liat (11/29/22 13:46:00) Rapid Influenza A PCR: Detected Abnormal (11/29/22 13:46:00) Rapid Influenza B PCR: Not Detected (11/29/22 13:46:00) Diagnostics Radiology Results - Last 24 hours Across Visits 11/29/2022 12:24 - CTA Chest WO/W IV Contrast IMPRESSION:1. No evidence of aortic dissection.2. Dilatation of ascending thoracic aorta measuring up to 4.9 cm.3. Moderate to severe atherosclerosis with moderate/severe ostialstenosis of the celiac artery and mild ostial stenosis of the SMA.4. Patchy consolidative opacities in the right middle lobe and medial right lung base, likely infectious in etiology.5. Other ancillary findings as above. Thank you for consulting our team of subspecialty radiologists Radiology. Healthcare providers wishing to discuss this case further can contact. 11/29/2022 12:24 - CTA Abd/Pelvis WO/W IV Contrast IMPRESSION:1. No evidence of aortic dissection.2. Dilatation of ascending thoracic aorta measuring up to 4.9 cm.3. Moderate to severe atherosclerosis with moderate/severe ostialstenosis of the celiac artery and mild ostial stenosis of the SMA.4. Patchy consolidative opacities in the right middle lobe and medial right lung base, likely infectious in etiology.5. Other ancillary findings as above. Thank you for consulting our team of subspecialty radiologists at Radiology. Healthcare providers wishing to discuss this case further can contact the Hospital. For after-hours or emergency department cases. 11/29/2022 12:24 - CT Head W/o IV Contrast IMPRESSION: 1. No CT evidence of acute intracranial hemorrhage, mass effect orhydrocephalus.2. Age indeterminate lacunar infarct in the right corpus striatum with background of chronic microvascular ischemic disease and chronic cortical infarct in the left frontal lobe.3. Features of acute right maxillary sinusitis. Thank you for consulting our team of subspecialty Radiology. Healthcare providers wishing to discuss this case further can contact the hospital. For after-hours or emergency department cases. Signature Line Electronically Signed on 11/29/22 17:57 ________________________________________________________ MD

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2551286

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

mild
Staat
CT
Alter
74,0
Geschlecht
F
Eingang
05.01.2023
Impfdatum
22.11.2022
Beginn
24.11.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exercise tolerance decreased Injection site pain

Symptomtext

I received the high dose vax in my left arm. A couple of days after the injection my arm in that area became sore. The soreness was intermittent and came and went. I still have the soreness but it's not that sore as it was. It seems to come in on that area after exercising and inclement weather.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
CoQ10, Vit D, Calmag, Vit C
Allergien
Sulfa
Vorherige Impfungen
-

VAERS 2051281

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933ac

mild
Staat
MA
Alter
82,0
Geschlecht
F
Eingang
05.01.2023
Impfdatum
20.01.2021
Beginn
05.01.2023
Tage bis Beginn
715,0
Dosis
UNK
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Aphonia COVID-19 Cough Fatigue Nasopharyngitis SARS-CoV-2 test positive

Symptomtext

cold like symptoms nonproductive cough, loss of voice, fatigue

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
Rapid tested with POSITIVE results
Aktuelle Erkrankungen
n/a
Vorgeschichte
Dementia, Alzheimer's, Hypertension, Alcohol abuse, Liver disease, abnormalities of gait and mobility, Vit D deficiency, gastro-esophageal reflux disease without esophagit
Andere Medikamente
Alprazolam, aspirin, atorvastatin, cholecalciferol, cyanocobalamin, famotidine, miralax, mirtazapine, nephro-vite, seroquel, tylenolol,
Allergien
Trazodone- insomnia, aggression
Vorherige Impfungen
-

VAERS 2522546

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

mild
Staat
NM
Alter
85,0
Geschlecht
M
Eingang
03.12.2022
Impfdatum
23.11.2022
Beginn
23.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Eye swelling Pruritus Skin exfoliation

Symptomtext

RECEIVED FLU AND BIVALENT COVID VACCINE ON 11/23/2022 AND ON SATURDAY 11/26/2022 HE STATES HE STARTED TO ITCH ON HEAD AND ARMS AND OVER TIME GOT WORSE. THIS MORNING ON 11/30/2022 THE SKIN ON HIS FACE LOOKS PEELED AND EYES ARE SWOLLEN LEFT EYE DID CLOSE UP PATIENT ALSO FEELS DIZZY. PATIENT GIVEN DECADRON 10MG AND KENALOG 40 SHOT ADMINISTERED DURING THE VISIT. BENADRYL 25MG BY MOUTH EVERY 6 HOURS FOR THE NEXT 2 DAYS.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
-
Andere Medikamente
NORVASC,VITAMINB12, CARDURA,FISH OIL, POLY VITAMIN, BENICAR HCT, CIALIS, FLOMAX, VITAMIN E, DIOVAN,
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2515899

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

mild
Staat
AZ
Alter
14,0
Geschlecht
F
Eingang
24.11.2022
Impfdatum
13.11.2022
Beginn
13.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Injection site pain Product administered to patient of inappropriate age Vaccination site pain

Symptomtext

a sore arm at injection site; FLUZONE HIGH DOSE QIV was inadvertently administered to a 14-year-old patient; FLUZONE HIGH DOSE QIV was inadvertently administered to a 14-year-old patient; Initial information was received on 14-Nov-2022 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 14 years old female patient who experienced a sore arm at injection site and fluzone high dose qiv was inadvertently administered to a 14-year-old patient after receiving influenza quadrival A-B high dose HV vaccine [Fluzone high-dose quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included COVID-19 vaccine for Immunisation. On 13-Nov-2022, the patient received 0.7 ml dose of suspect influenza quadrival A-B high dose HV vaccine (unknown formulation, strength) (expiry date: 30-Jun-2023 frequency: once) (lot:UJ933AC) via intramuscular route in the right arm for Immunization. On 13-Nov-2022 the patient had a non-serious event a sore arm at injection site (vaccination site pain), fluzone high dose qiv was inadvertently administered to a 14-year-old patient (accidental exposure to product) and (Product administered to patient of inappropriate age) (Latency: same day) following the administration of influenza quadrival A-B high dose HV vaccine. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Not Recovered / Not Resolved for the event a sore arm at injection site, was Unknown for the events fluzone high dose qiv was inadvertently administered to a 14-year-old patient. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
COVID-19 VACCINE
Allergien
-
Vorherige Impfungen
-

VAERS 2512783

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

mild
Staat
MN
Alter
67,0
Geschlecht
M
Eingang
21.11.2022
Impfdatum
18.11.2022
Beginn
18.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cellulitis Infection Pain in extremity Pyrexia Rash Tenderness

Symptomtext

Patient called nurse triage the morning of 11/20/22, reporting he received both the influenza and pneumonia shot, in the right arm, Friday morning 11/18/22. He had a new rash, was feverish during the night. Right arm is sore, tender. He came to the urgent care clinic connected to the pharmacy the same morning, was diagnosed with cellulitis, and given sulfamethoxazole-trimethoprim to treat the infection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Gabapentin, celecoxib, oxycodone-acetaminophen, fluticasone
Allergien
Rosuvastatin, morphine and related, simvastatin
Vorherige Impfungen
-

VAERS 2512503

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933ac

mild
Staat
NY
Alter
86,0
Geschlecht
F
Eingang
20.11.2022
Impfdatum
13.11.2022
Beginn
16.11.2022
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site bruising Injection site erythema Injection site swelling

Symptomtext

Site: Bruising at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2510834

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933ac

mild
Staat
AZ
Alter
70,0
Geschlecht
M
Eingang
17.11.2022
Impfdatum
06.11.2022
Beginn
06.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Pain Pyrexia

Symptomtext

Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Fever-Severe

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2507188

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933ac

mild
Staat
AZ
Alter
14,0
Geschlecht
F
Eingang
14.11.2022
Impfdatum
13.11.2022
Beginn
13.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Injection site erythema Injection site pain Injection site swelling Pain Pyrexia

Symptomtext

Advised to use ice pack on injection site for swelling, redness, soreness, 15-20 minutes on /off Advised to use IBU, APAP or pain reliever for overall aches, pains, low grade fever, headache

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Thyroid disease
Vorgeschichte
Thyroid disease
Andere Medikamente
levothyroxine 0.025mg
Allergien
nothing list on VAR form.
Vorherige Impfungen
-

VAERS 2506958

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933ac

mild
Staat
WI
Alter
69,0
Geschlecht
F
Eingang
14.11.2022
Impfdatum
07.11.2022
Beginn
09.11.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site swelling Injection site warmth

Symptomtext

Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: patient called to report a band of redness around her arm below where she received immunization. she also said it was warm to the touch and quite painful. advised pt to contact md in case it was cellulitis. rx later came over for keflex

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2499883

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

mild
Staat
CT
Alter
85,0
Geschlecht
F
Eingang
05.11.2022
Impfdatum
30.10.2022
Beginn
31.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus Rash

Symptomtext

Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2497370

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

mild
Staat
CT
Alter
83,0
Geschlecht
F
Eingang
03.11.2022
Impfdatum
26.10.2022
Beginn
30.10.2022
Tage bis Beginn
4,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site pruritus Injection site swelling Injection site warmth

Symptomtext

Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Medium, Additional Details: Localized redness at injection site. warm to the touch with mild swelling. Soreness after 2 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2493310

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933ac

mild
Staat
VA
Alter
73,0
Geschlecht
F
Eingang
29.10.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Dizziness Headache Pain in extremity

Symptomtext

Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Headache-Medium, Additional Details: In addition to above, pt also complained of an "ache that went all the way into her hand" on the arm that was immunized (right).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2491570

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

mild
Staat
TX
Alter
68,0
Geschlecht
M
Eingang
27.10.2022
Impfdatum
14.10.2022
Beginn
15.10.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Allodynia Blister Erythema Pain

Symptomtext

within 1-2 days of administration, pt describes erythema, pain, allodynia, and a blister

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
Hep C HTN CAD
Andere Medikamente
Current Outpatient Medications: ? alprazolam (XANAX) 0.25 MG tablet, TAKE ONE (1) TABLET BY MOUTH 3 TIMES DAILY AS NEEDED FOR SLEEP OR ANXIETY., Disp: 60 Tablet, Rfl: 0 ? B COMPLEX-C-E OR, Take 1 Tablet by mouth daily., Disp: , Rfl: ?
Allergien
iodine, bee/wasp sting,
Vorherige Impfungen
-

VAERS 2491517

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933ac

mild
Staat
MD
Alter
81,0
Geschlecht
F
Eingang
27.10.2022
Impfdatum
24.10.2022
Beginn
25.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus Injection site rash

Symptomtext

RAsh and redness at the site of injection which is slightly itchy

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2571789

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

gering
Staat
NC
Alter
79,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
26.10.2022
Beginn
17.01.2023
Tage bis Beginn
83,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Medication error No adverse event

Symptomtext

patient was administered an extra dose of fluzone high dose qiv with no reported adverse event; Initial information received on 25-Jan-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 79 years old female patient where patient was administered an extra dose of fluzone high dose qiv with no reported adverse event while receiving vaccine influenza quadrival a-b high dose hv vaccine [fluzone high-dose quadrivalent]. The patient's past medical history, medical treatment(s), concomitant medication(s) and family history were not provided. On 26-Oct-2022 patient received 0.7 ml daily (QD) dose of suspect influenza quadrival a-b high dose hv vaccine (batch number- UJ933AC) via intramuscular route in the left arm (formulation, strength and expiration date: not provided) as Immunization and on 17-Nov-2022, the patient also received same vaccine lot number not reported via intramuscular route in the right arm. On 17-Jan-2023 the patient was administered an extra dose of fluzone high dose qiv with no reported adverse event (incorrect dose administered) 2 months 22 days following the administration of influenza quadrival a-b high dose hv vaccine. Action taken- Not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2551614

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

gering
Staat
ND
Alter
78,0
Geschlecht
M
Eingang
05.01.2023
Impfdatum
21.12.2022
Beginn
22.12.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthritis Erythema Feeling hot Grip strength decreased Joint swelling Muscular weakness X-ray abnormal

Symptomtext

severe swelling, pain, redness, and warmth to RIGHT wrist and hand hand is weak and he is unable to grip and functionally use the hand for 2 weeks

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthritis
Hospital-Tage
-
Labordaten
xray done mild arthritis is seen
Aktuelle Erkrankungen
-
Vorgeschichte
chronic diabetic foot ulcer, chronic kidney disease stage 4
Andere Medikamente
levothyroxine, insulin, lipitor, plavix, amlodipine, coreg, torsmide , tums, imdur, sodium bicarbonate
Allergien
none
Vorherige Impfungen
-

VAERS 2527380

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
09.12.2022
Impfdatum
08.11.2022
Beginn
08.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Poor quality product administered Product storage error

Symptomtext

the temperature reached 55.5 degrees f for 92 hours with no reported adverse event; vaccines were out of range for a cumulative period of 94 hours, this was not realized until yesterday, by which time some of the vaccines had been administered with no reported adverse event; Initial information received on 09-Nov-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case is linked to case 2022SA465778 (CLUSTER). This case involves an unknown age and gender patient, reported temperature reached 55.5 degrees f for 92 hours and vaccines INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] were out of range for a cumulative period of 94 hours, this was not realized until yesterday, by which time some of the vaccines had been administered with no reported adverse event. Concomitant vaccine: shingles vaccine. The patient's past medical history, medical treatment(s) and family history were not provided. On 08-Nov-2022, the patients received suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE at dose of 0.7ml total, Strength: high-dose (formulation: unknown) (lot number: UJ933AC and expiry date: 30-Jun-2023) and 0.5 ml suspension for injection (lot: UT7695KA) (expiry date, strength: unknown) via intramuscular route in unknown administration site for Immunisation and the temperature reached 55.5 degrees F for 92 hours with no reported adverse event (product storage error) and vaccines were out of range for a cumulative period of 94 hours, this was not realized until yesterday, by which time some of the vaccines had been administered with no reported adverse event (poor quality product administered) (latency: same day). It was reported, MA is checking stability of vaccines due to a refrigerator malfunction on 04Nov2022. She states some patients received the vaccine post excursion, what is the protocol for these patients? HCP states that after the power outage, they thought the refrigerator was working properly, but there was an "auto reset" feature that they were unaware of, so products did not return to stability recommendations. Medical Assistant reports 1 FLUZONE HIGH-DOSE QUADRIVALENT was given. Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE HIGH-DOSE QUADRIVALENT) was not applicable. At time of reporting, the outcome was Unknown for both events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Additional information was received on 02-Dec-2022 via other healthcare professional: case is upgraded from non valid to valid , number of number and dose of suspect updated. Text amended accordingly.; Sender's Comments: 01359841:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2523204

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

gering
Staat
OR
Alter
66,0
Geschlecht
M
Eingang
05.12.2022
Impfdatum
09.11.2022
Beginn
10.11.2022
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Tinnitus

Symptomtext

Tinnitus started within 24 hours of receiving vaccine. It is current and has been constant since starting.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tinnitus
Hospital-Tage
-
Labordaten
We are in the process of getting the patient into a specialist for testing.
Aktuelle Erkrankungen
None
Vorgeschichte
Asthma, Hypertension, BPH w/LUTS, Elevate PSA, Hypothyroidism, Hyperlipidemia, Pre-Diabetes, Monitoring for Longterm anticoagulant use
Andere Medikamente
atorvastatin calcium (tablet) atorvastatin 40 mg Take 1 (one) tablet (40 mg total) by mouth every evening. cyanocobalamin (vitamin B-12) (tablet, sublingual) cyanocobalamin (vitamin B-12) 5,000 mcg Place under the tongue. flaxseed Take
Allergien
None
Vorherige Impfungen
-

VAERS 2522548

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

gering
Staat
-
Alter
84,0
Geschlecht
F
Eingang
03.12.2022
Impfdatum
03.12.2022
Beginn
03.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

Patient came in to receive Pneumonia vaccine. Pharmacist accidently gave the Flu vaccine which the patient had already received 1.5 months back

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2512811

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

gering
Staat
NY
Alter
79,0
Geschlecht
F
Eingang
21.11.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Vaccine had a low temp excursion. Was revaccinated on 10/26/2022 per recommendation of Sanofi-Pasteur.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2510788

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

gering
Staat
NY
Alter
71,0
Geschlecht
F
Eingang
17.11.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Vaccine had a low temp excursion. Declined revaccination as recommended by Sanofi-Pasteur

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2510780

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

gering
Staat
NY
Alter
72,0
Geschlecht
M
Eingang
17.11.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Vaccine had a low temp excursion. Revaccinated per Sanofi-Pasteur recommendation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2510767

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

gering
Staat
NY
Alter
80,0
Geschlecht
F
Eingang
17.11.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered Product storage error

Symptomtext

Vaccine experienced a low temperature excursion. Patient revaccinated on 10/26/22 per recommendations of Sanofi_Pasteur

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2509961

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AC

gering
Staat
CO
Alter
66,0
Geschlecht
M
Eingang
16.11.2022
Impfdatum
16.11.2022
Beginn
16.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

Patient name and DOB identified and verified what we were doing today (Flu vaccine and Shingles vaccine). Patient agreed with plan. Here with family if needed help understanding my questions. Flu shot administered and then family said he only needed the Shingles vaccine and that he had already had the flu vaccine. Patient told family it was in September but it was given in October 2022. Had patient wait in clinic for 20 minutes. No adverse effects noted. Patient advised to go to ER if he experiences anything overnight. Patient in agreement with plan.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-